Literature DB >> 6279504

Enhanced vasodilatation in essential hypertension by calcium channel blockade with verapamil.

U L Hulthén, P Bolli, F W Amann, W Kiowski, F R Bühler.   

Abstract

The dependency of arteriolar tone on calcium influx was studied in 11 patients with essential hypertension (EH) and compared to 11 age-matched normotensive subjects (NT) by measuring the forearm blood flow response to intraarterial infusion of the calcium channel blocker verapamil (Verap) and the non-specific vasodilator sodium nitroprusside (Nip) using venous occlusion plethysmography. Verap in incremental dosages from 1 to 75 micrograms/100 ml forearm tissue induced a greater increase in forearm blood flow ( delta FAF) in EH then in NT, whereas there was no significant difference in delta FAF following Nip 1,2 micrograms/100 ml tissue. Delta FAF to Verap as adjusted for delta FAF to Nip was still greater in EH than in NT. Delta FAF to all dosages of Verap correlated positively with basal plasma epinephrine concentration in EH. At the two highest dosages of Verap, systemic blood pressure fell in EH, and the Verap-induced vasodilator (as adjusted for the response to Nip) correlated negatively to plasma renin activity or plasma angiotensin II concentration. These findings support the concept of an increased dependency of arteriolar tone on calcium influx in EH, which is related to the activity of the sympathetic nervous system. This association may be due to a common underlying derangement in transmembranous ionic fluxes in smooth muscle cells and sympathetic neurons in EH.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6279504

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  12 in total

1.  Intracellular calcium and blood pressure: comparison between primary hyperparathyroidism and essential hypertension.

Authors:  C Fardella; J A Rodriguez-Portales
Journal:  J Endocrinol Invest       Date:  1995-12       Impact factor: 4.256

2.  The effect of 8 weeks treatment with the calcium antagonist felodipine on blood pressure, heart rate, working capacity, plasma renin activity, plasma angiotensin II, urinary catecholamines and aldosterone in patients with essential hypertension.

Authors:  P L Katzman; U L Hulthén; B Hökfelt
Journal:  Br J Clin Pharmacol       Date:  1986-06       Impact factor: 4.335

Review 3.  Antihypertensive treatment according to age, plasma renin and race.

Authors:  F R Bühler
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

Review 4.  Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  H A Friedel; E M Sorkin
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

5.  The effect of acute and chronic nicardipine therapy on forearm arterial haemodynamics in essential hypertension.

Authors:  J Levenson; A C Simon; J Bouthier; B C Maarek; M E Safar
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

6.  Vasodilatory effect of nicardipine and verapamil in the forearm of hypertensive as compared with normotensive man.

Authors:  U L Hulthén; P Bolli; F R Bühler
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

7.  Hypotensive effects of diltiazem to normals and essential hypertensives.

Authors:  K Aoki; K Sato; S Kondo; M Yamamoto
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  Effect of treatment with chlorthalidone and atenolol on response to dilator agents in the forearm resistance vessels of men with primary hypertension.

Authors:  B F Robinson; R J Dobbs; R J Phillips
Journal:  Br J Clin Pharmacol       Date:  1983-09       Impact factor: 4.335

9.  The β3 subunit contributes to vascular calcium channel upregulation and hypertension in angiotensin II-infused C57BL/6 mice.

Authors:  Sujay V Kharade; Swapnil K Sonkusare; Anup K Srivastava; Keshari M Thakali; Terry W Fletcher; Sung W Rhee; Nancy J Rusch
Journal:  Hypertension       Date:  2012-11-05       Impact factor: 10.190

Review 10.  Current drug treatment and treatment patterns with antihypertensive drugs.

Authors:  E D Freis; V Papademetriou
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.